Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children

Pediatric Infectious Disease Journal

Volumn 18, Issue 2, 1999, Pages 134-142

  Read, Jennifer S ^a   Bethel, James ^a   Robert Harris, D ^a,b   Meyer III, William A ^a   Korelitz, James ^c   Mofenson, Lynne M ^a   Move Jr , John ^d   Pahwa, Savita ^c   Rich, Kenneth ^d   Nugent, Robert P ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Disease progression; Human immunodeficiency virus; Mortality; Vitamin A

Indexed keywords

COTRIMOXAZOLE; IMMUNOGLOBULIN; RETINOL; VIRUS RNA;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GROWTH DISORDER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHASE 3 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTICAL TRANSMISSION; VITAMIN BLOOD LEVEL;

EID: 0032996178     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199902000-00010     Document Type: Article

References (44)

1. Green HN, Mellanby E. Vitamin A as an anti-infective agent. Br Med J 1928;2:691-6.
2. Semba RD, Muhilal, Scott AL, et al. Depressed immune response to tetanus in children with vitamin A deficiency. J Nutr 1992;122:101-7.
3. Semba RD, Munasir Z, Beeler J, et al. Reduced seroconversion to measles in infants given vitamin A with measles vaccination. Lancet 1995;345:1330-2.
4. Semba RD, Muhilal, Ward BJ, et al. Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet 1993;341: 5-8.
5. Carman JA, Smith SM, Hayes CE. Characterization of a helper T lymphocyte defect in vitamin A-deficient mice. J Immunol 1989; 142:388-93.
6. Markowitz LE, Nzilambi N, Driskell WJ, et al. Vitamin A levels and mortality among hospitalized measles patients, Kinshasa, Zaire. J Trop Pediatr 1989;35:109-12.
7. Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, Fauci AS. Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells. Proc Natl Acad Sei USA 1992;89:2689-93.
8. Kitano K, Baldwin GC, Raines MA, Golde DVV. Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. Blood 1990;76:1980-8.
9. Turpin JA, Vargo M, Meltzer MS. Enhanced HFV-1 replication in retinoid-treated monocytes: retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression. J Immunol 1992;148:2539-46.
10. Tang AM, Graham NMH, Kirby AJ, McCall LD, Willett WC, Saah AJ. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HlV-l)-infected homosexual men. Am J Epidemiol 1993;138:937-51.
11. Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:949-58.
12. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 1996;143:1244-56.
13. Karter DL, Karter AJ, Yarrish R, et al. Vitamin A deficiency in non-vitamin-supplemented patients with AIDS: a crosssectional study. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:199-203.
14. Ward B J, Humphrey JH, Clement L, Chaisson RE. Vitamin A status in HIV infection. Nutr Res 1993;13:157-66.
15. Beach RS, Mantero-Atienza E, Shor-Posner G, et al. Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS 1992;6:701-8.
16. Baum MK, Shor-Posner G, Lu Y, et al. Micronutrients and HIV-1 disease progression. AIDS 1995;9:1051-6.
17. Semba RD, Graham NMH, Caiaffa WT, Margolick JB, Clément L, Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993;153:2149-54.
18. Semba RD, Caiaffa WT, Graham NMH, Cohn S, Vlahov D. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis 1995;171:1196-202.
19. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343:1593-7.
20. Greenberg BL, Semba RD, Vink PE, et al. Vitamin A deficiency and maternal-infant transmission of HP/ in two metropolitan areas in the United States. AIDS 1997;11:325-32.
21. Burger H, Kovacs A, Weiser B, et al. Maternal serum vitamin A levels are not associated with mother-to-child transmission of HIV-1 in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:321-6.
22. Semba RD, Miotti PG, Chiphangwi JD, et al. Infant mortality and maternal Vitamin A deficiency during human immunodeficiency virus infection. Clin Infect Dis 1995;21:966-72.
23. Semba RD, Miotti P, Chiphangwi JD, et al. Maternal vitamin A deficiency and child growth failure during human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:219-22.
24. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. N Engl J Med 1991;325:73-80.
25. Mofenson LM, Moye J, Bethel J, Hirschhorn R, Jordan C, Nugent R, for the National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 X 109/L or more: effect on viral, opportunistic and bacterial infections. JAMA 1992;268:483-8.
26. Mofenson LM, Bethel J, Moye J, Flyer P, Nugent R, for the National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:1103-13.
27. Mofenson LM, Moye J, Korelitz J, Bethel J, Hirschhorn R, Nugent R, for the National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1994;13:477-84.
28. Centers for Disease Control. Classification system for human immunodeficiency virus infection in children under 13 years of age. MMWR 1987;36:225-36.
29. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43(RR-12):1-10.
30. Mofenson LM, Korelitz J, Meyer WA III, et al. for the National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. J Infect Dis 1997;175:1029-38.
31. Lin HJ, Myers LE, Yen-Lieberman B, et al. Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J Infect Dis 1995;170:55362.
32. Cook JD, Koch TR, Knoblock EC. Separation and quantitation of serum tocopherols and retinol by high performance liquid chromatography [Abstract]. Clin Chem 1986;32:1193.
33. Underwood BA. Biochemical and histological methodologies for assessing vitamin A status in human populations. Methods Enzymol 1990;190:242-51.
34. Underwood BA. Methods for assessment of vitamin A status J Nutr 1990;120:1459-63.
35. Periquet BA, Jammes NM, Lambert WE, et al. Micronutrient levels in HIV-1 infected children. AIDS 1995;9:887-93.
36. Henderson RA, Talusan K, Hutton N, Yolken RH, Cahallero B. Serum and plasma markers of nutritional status in children infected with the human immunodeficiency virus. J Am Diet Assoc 1997;97:1377-81.
37. Pilch SM, ed. Assessment of the vitamin A nutritional status of the U. S. population based on data collected in the Health and Nutrition Examination Surveys. Bethesda, MD: Life Sciences Research Office (Federation of American Societies for Experimental Biology), 1985.
38. Butler JC, Havens PL, Sowell AL, et al. Measles severity and serum retinol (vitamin A) concentration among children in the United States. Pediatrics 1993;91:1176-81.
39. Frieden TR, Sowell AL, Henning KJ, Huff DL, Gunn RA. Vitamin A levels and severity of measles: New York City. Am J Dis Child 1992;146:182-6.
40. Arrieta AC, Zaleska M, Stutman HR, Marks MI. Vitamin A levels in children with measles in Long Beach, California. J Pediatr 1992;121:75-8.
41. Neuzil KM, Gruber WC, Chytil F, Stahlman MT, Engelhardt B, Graham BS. Serum vitamin A levels in respiratory syncytial virus infection. J Pediatr 1994;124:433-6.
42. Goetghebuer T, Brasseur D, Dramaix M, et al. Significance of very low retinol levels during severe protein-energy malnutrition. J Trop Pediatr 1996;42:158-61.
43. Temple VJ, Ighogboja IS, Okonji MC. Serum vitamin A and beta-carotene levels in pre-school age children. J Trop Pediatr 1994;40:374-5.
44. Tang AM, Graham NMH, Semba RD, Saah AJ. Association between serum vitamin A and E levels and HW-1 disease progression. AIDS 1997;11:613-20.